Oxytocin may well have established its reputation as the ‘social hormone’ in the popular imagination, but it has no effect on symptoms in children with autism, according to a study published 26 July in the Journal of Autism and Developmental Disorders.

Spending a month in a stimulating cage filled with wheels and toys alleviates repetitive grooming in a mouse model of autism, according to a study published 28 June in Autism Research.

Teasing apart the link between autism and epilepsy opens the door for a possible preventive option for some cases of autism. But is the potential worth the risks?

Some children with autism and hyperactivity have a genetic intolerance to methylphenidate (Ritalin), the drug commonly prescribed for attention deficit hyperactivity disorder, reports a new study published 16 July in Pharmacogenomics.

Using telemedicine, physicians can diagnose autism at a distance almost as well as they can in person, reports a new study published 19 July in Telemedicine and e-Health.

New findings identifying the targets of antibodies found in mothers of children with autism add to mounting evidence that the prenatal immune environment can alter fetal brain development, and perhaps lead to autism. Now what?

School-based interventions are arguably the best way to reach the truly underserved, under-represented and under-resourced children with autism, says Connie Kasari.

Ritalin lowers impulsivity, oppositional behavior and attention deficit in children with autism and has mild side effects, reports a study published 19 June in the Journal of Child and Adolescent Psychiatry.

Introducing gut bacteria to mice that lack them increases their sociability, but mainly with familiar mice, reports a study published 21 May in Molecular Psychiatry.

The majority of people lacking a functional copy of the SHANK3 gene have both autism and severe intellectual disability, according to a study published 11 June in Molecular Autism.